Answers are grounded in this paper and cite their sources.
The discovery that anesthetic-induced immobility is mediated primarily in the spinal cord1–3has led to a growing interest in studying anesthetic mechanisms at the level of neural circuits and systems.4,5Recent studies suggest that the process of emergence from general anesthesia is distinct from the process of induction,6and, in particular, the roles of ascending arousal pathways in emergence from general anesthesia are becoming recognized.4,5,7Cholinergic,8–10noradrenergic,11histaminergic,12,13and orexinergic14,15arousal pathways have been implicated in emergence from general anesthesia, but the role of dopamine remains unclear.It is widely accepted that dopamine plays an important role in behavioral arousal.16–18Electrolytic lesions of dopaminergic neurons have been shown to induce a coma-like state,19and mice with selective loss of dopamine in the brain appear hypoactive and apathetic.20Dopaminergic neurons in the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) send projections to key arousal-promoting brain regions, including the dorsal raphe, locus ceruleus, pedunculopontine and laterodorsal tegmental areas, basal forebrain, and the perifornical area of the lateral hypothalamus, and, in turn, these arousal-promoting centers also send inputs to the VTA and SNc.16The existence of these projections alone suggests that dopamine is intimately involved in regulating arousal.Recent studies show that methylphenidate induces emergence from general anesthesia with isoflurane21and propofol.22However, methylphenidate is known to inhibit both dopamine and norepinephrine reuptake transporters with similar affinities (Ki= 250 nM and 150 nM, respectively),23and both are known to promote arousal. The current study was performed in adult rats to test the hypothesis that selective activation of dopaminergic neurotransmission is sufficient to induce emergence from isoflurane general anesthesia. First, we tested the effects of the specific D1 and D2 dopamine receptor agonists chloro-APB and quinpirole, respectively, on time to emergence from a standardized isoflurane general anesthetic. We then tested the behavioral effects of chloro-APB and quinpirole during continuous isoflurane general anesthesia. In a separate group of rats with preimplanted electrodes, we recorded the electroencephalogram during isoflurane general anesthesia and performed spectral analysis to compare the recordings taken before and after dopamine agonist administration.All studies were approved by the Massachusetts General Hospital Subcommittee on Research Animal Care (Boston, Massachusetts), which serves as our Institutional Animal Care and Use Committee. Ten male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA) were used for this study. The age range was approximately 3–6 months, and the weight range was 322–565 g. The same six rats were used in random order for all behavioral experiments, whereas a separate group of four rats were used for all electroencephalogram recordings. Each animal was provided with at least 3 days of rest between experiments. Animals were kept on a standard day–night cycle (lights on at 7:00 AM and off at 7:00 PM), and all experiments were performed during the day. Because rats are nocturnal animals, all experiments were conducted during the “night” phase of the rat sleep–wake cycle.After inducing general anesthesia with isoflurane (2–3%) in oxygen, a 24-gauge intravenous catheter was placed in a lateral tail vein, a rectal temperature probe was inserted, and the animal was placed in a cylindrical acrylic anesthetizing chamber, as previously described.21A heating pad was placed under the chamber to maintain rectal temperature between 36.5°C and 37.4°C. Gas was continuously sampled from the distal portion of the chamber, and isoflurane, oxygen, and carbon dioxide concentrations in the chamber were monitored using a calibrated Ohmeda 5250 anesthetic agent analyzer (GE Healthcare, Waukesha, WI).Isoflurane was purchased from Henry Schein (Melville, NY). The D1 receptor agonist chloro-APB (6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide), the D2 receptor agonist quinpirole (trans-(–)-(4aR)-4, 4a, 5, 6, 7, 8, 8a, 9-Octahydro-5-propyl-1H-pyrazolo[3,4-g]quinoline monohydrochloride), and the D1 receptor antagonist SCH-23390 (R(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride) were purchased from Sigma–Aldrich (St. Louis, MO). All drugs were dissolved in normal saline to a final volume of 0.5 ml and administered intravenously via the lateral tail vein catheter. Chloro-APB solutions were sonicated in an ultrasound water bath to facilitate dissolution. The IV tubing (approximate volume 0.6 ml) was always flushed with 2 ml of normal saline after drug administration to ensure complete delivery.The inhaled concentration of isoflurane was fixed at 1.5% (approximately 1 median alveolar concentration). After 40 min, rats received normal saline IV, chloro-APB (3 mg/kg IV), or quinpirole (5 mg/kg IV). Isoflurane was continued for 5 additional minutes, after which the rat was taken out of the chamber, and the temperature probe was removed. The animal was placed supine on a warming pad and inspired room air. Time to emergence was defined as the time from termination of isoflurane to return of righting (i.e. , all four paws touching the floor).The isoflurane concentration was held at a dose that produced loss of righting with no purposeful movement for 40 consecutive minutes, as described previously.21Purposeful movements were defined as any movements other than random muscle twitches, such as lifting of the head, opening of the eyes, twisting of the torso, kicking, clawing, chewing, licking, or grooming. The intravenous catheter was then flushed with 2 ml of normal saline. Five minutes after this injection, quinpirole (5 mg/kg IV) or chloro-APB was administered. To establish a dose–response relationship, three different doses of chloro-APB (0.03 mg/kg, 0.3 mg/kg, or 3 mg/kg IV) were administered on different days. In a separate experiment, the D1 receptor antagonist SCH-23390 (0.2 mg/kg IV) was administered instead of the normal saline control, followed 5 min later by chloro-APB (3 mg/kg IV). The same six rats were used for each experimental condition, in random order, with at least 3 days of rest between experiments. After intravenous drug administration, each animal continued to inhale the same dose of isoflurane for 30 min or until restoration of righting occurred.Extradural electroencephalogram electrodes were implanted surgically at least 7 days before recording, as detailed previously.21,22Briefly, rats were placed in a stereotaxic frame (David Kopf Instruments, Tujunga, CA) under isoflurane general anesthesia. A microdrill (Patterson Dental Supply Inc., Wilmington, MA) was used to make four holes at the following stereotactic coordinates: A0L0, A6L3, A6L-3, and A10L2 relative to the lambda.24An electrode with mounting screw and socket (Plastics One, Roanoke, VA) was screwed into each hole, and the sockets were inserted in a pedestal (Plastics One) before being fixed permanently with dental acrylic cement.On the day of an experiment, the potential difference between electrodes A0L0 and A6L3 (right somatosensory cortex) or between electrodes A0L0 and A6L-3 (left somatosensory cortex) was recorded based on which signal gave less motion artifact. The signal was referenced to A10L2 and recorded using a QP511 Quad AC Amplifier System (Grass Instruments, West Warwick, RI) and a USB-6009 14-bit data acquisition board (National Instruments, Austin, TX). The sampling rate was 512 Hz, and no line filter was used. Data were filtered between 0.3 Hz and 50 Hz. Baseline recordings were taken for 10 min in the awake state before any drugs were administered. The rats were then anesthetized with isoflurane and placed in the anesthetizing chamber in the prone position with the isoflurane dose fixed at 1.0%. After a minimum isoflurane exposure of 40 min, normal saline or SCH-23390 (0.2 mg/kg IV) was administered and the temperature probe was removed. Five minutes later, either chloro-APB (3 mg/kg IV) or quinpirole (5 mg/kg IV) was administered, and isoflurane anesthesia was continued at the same dose for an additional 30 min.Spectral analysis was performed using Matlab 7.11 (Mathworks, Natick, MA) and the Chronux software (Cold Spring Harbor, NY), as previously described.21,22Briefly, spectrograms were calculated using sliding windows of 2-s duration stepped through 0.05 s. The resulting spectral estimates have a bandwidth of 1.5 Hz. Mean power spectra were compared before and after quinpirole or chloro-APB administration using the Kolmogorov–Smirnov test. To determine the difference between two spectra, a two-sample Kolmogorov–Smirnov test was performed on the spectral power as a function of frequency computed from the 30 windows in the preagonist and postagonist periods. We used a Bonferroni correction to adjust the significance level for multiple hypothesis testing.Prism 5.04 (Graphpad Software, San Diego, CA) and Matlab R2010b (Mathworks) were used for statistical analysis, and, when possible, results are reported in terms of 95% CI based on Z-tests, t tests, or Mann–Whitney tests. We used a Bayesian Monte Carlo procedure to compute Bayesian 95% CI (credibility) to assess the effect of the different agonists on return of righting during continuous isoflurane general anesthesia, as described previously.21,22The posterior densities for the differences in the proportion of animals that had return of righting were computed by using standard Matlab simulation procedures. Instead of P values for the Bayesian analyses, we computed the posterior probability that the propensity to right was greater in one group than in the other. A one-way ANOVA was used to assess whether there were significant differences among the final isoflurane doses in each animal group. To provide a conservative check on the assessments made by the 95% CI, the nonparametric tests were also used to assess statistical significance. The Mann–Whitney test was used to test the hypothesis that chloro-APB hastens time to emergence from isoflurane general anesthesia. We used the two-sided Kolmogorov–Smirnov test with a Bonferroni correction to compare spectra in animals before and after agonist administration.To characterize the righting propensity as a function of dose of chloro-APB and to conduct between-group comparisons of differences in righting propensity, we analyzed the data using a Bayesian logistic regression model with an uninformative prior density. In the Bayesian analysis, we used a Monte Carlo procedure to compute Bayesian 95% credibility (confidence) intervals for Pk— P1 . This is the difference in the righting propensities between the group that received dose k and the group that received normal saline. We define Pk as the righting propensity in the group that received dose k of chloro-APB and P1 as the righting propensity in the group that received normal saline. We denote k = 2 as the 0.03 mg dose, k = 3 as the 0.3 mg dose, and k = 4 as the 3 mg dose. Unlike CI computed using frequentist methods, the Bayesian 95% CI can be interpreted as having probability 0.95 that the value of Pk —P1 lies between the lower and upper limits of the interval based on the data in the current sample.25We applied this type of Monte Carlo algorithm in our previous studies using methylphenidate to induce active emergence from isoflurane and propofol general anesthesia.21,22The details of this Bayesian analysis are summarized in the appendix.We considered a result to be statistically significant based on the 95% CI if the interval does not contain zero. In this case, we have P value less than 0.05. In the case of the Bayesian analyses, the result is statistically significant if the relevant posterior probability was greater than 0.95.The protocol for this experiment is summarized in figure 1A. As shown in figure 1B, administration of chloro-APB (3 mg/kg IV) caused a significant reduction in time to emergence from isoflurane general anesthesia. The median time to emergence for animals that received normal saline was 330 s (95% CI: 160–577 s, n = 6) versus 50 s (95% CI: 12–130 s, n = 6) for animals that received chloro-APB. The median difference in time to emergence between these two groups was 222 s (95% CI: 77–534 s, Mann–Whitney test). This median difference was statistically significant (P = 0.0082).The median time to emergence for rats that received quinpirole (5 mg/kg IV) was 189 s (95% CI: 85–305 s, n = 6). The median difference in time to emergence between the normal saline control group and the quinpirole group was 155 s (95% CI: −30 to 417 s, Mann–Whitney test). This median difference was not statistically significant (P = 0.17). We report that the quinpirole result was not significant based on a sample of six animals per group, assuming a power of 0.8 and a type I error of 0.05, for an anticipated average difference of 199 s with an SD of 172 s, based on our previous results with methylphenidate.21That is, we designed the current study to detect emergence time effects that were at least as large as those we observed previously with methylphenidate.As illustrated in figure 2A, these experiments were conducted during continuous inhalation of isoflurane. The minimum concentration of isoflurane sufficient to maintain loss of righting was established for each rat, and this dose was continuously delivered to the chamber throughout the experiment. The average final dose of isoflurane was the same for all six experimental groups (1.0 ± 0.1%, mean ± SD), with no statistically significant difference between groups.As shown in figure 2B, the rats in the control group that received only normal saline (n = 6) did not exhibit an arousal response, and none had restoration of righting. However, six of six rats that received the D1 agonist chloro-APB (0.03 mg/kg IV) exhibited purposeful movements (defined as any movement other than a muscle twitch, such as lifting of the head, opening of the eyes, twisting of the torso, kicking, clawing, chewing, licking, or grooming) within 5 min of drug administration, and three of six rats had restoration of righting within 30 min, despite continuous inhalation of isoflurane at the same dose.Chloro-APB restored the righting reflex in a dose-dependent fashion. Restoration of righting occurred in four of six and five of six rats at chloro-APB doses of 0.3 mg/kg and 3 mg/kg, respectively. Although some rats failed to right themselves within 30 min of drug administration, all doses of chloro-APB produced an arousal response, despite continuous isoflurane anesthesia. At the highest dose of 3 mg/ kg, chloro-APB induced purposeful movements within 30 s in six of six rats. The Bayesian 95% CIs for the difference in the propensities to have restoration of righting between rats in the chloro-APB groups (0.03, 0.3 and 3 mg/kg) versus the normal saline group were 0.089–0.448, 0.236–0.913, and 0.349–0.987 respectively. The posterior probability that the difference was greater than 0 exceeded 0.99 for each comparison, indicating that each was statistically significant.In rats that received the D1 receptor antagonist SCH-23390 (0.2 mg/kg IV) 5 min before chloro-APB, the highest dose of chloro-APB (3 mg/kg IV) failed to restore the righting reflex. animals exhibited some movements after the administration of chloro-APB, but no other of arousal. The Bayesian 95% CI between rats that received normal saline versus SCH-23390 was with a posterior probability of indicating that the difference was statistically The D2 receptor agonist quinpirole (5 mg/kg IV) failed to an arousal during continuous isoflurane general anesthesia (n = data were recorded from rats with preimplanted experiments were performed in the prone position to motion with righting were computed from the continuous electroencephalogram data to in electroencephalogram power results from rats are shown in figure In awake rats electroencephalogram power was in the frequency range inhalation of isoflurane caused a large in power of normal saline produced no arousal and no in the but administration of the D1 agonist chloro-APB (3 mg/kg IV) induced behavioral of arousal (i.e. , purposeful movements such as kicking, in four of four as as a in power on the electroencephalogram with the D1 antagonist SCH-23390 (0.2 mg/kg IV) the arousal and in electroencephalogram power The D2 agonist quinpirole (5 mg/kg IV) failed to induce behavioral arousal or electroencephalogram during continuous isoflurane general anesthesia power spectra computed from four different rats during continuous isoflurane general anesthesia. the and used for Because the time to of the arousal was the 5 min after drug At any statistically significant differences between power spectra are in whereas the show differences that not statistical significance. As shown in figure with chloro-APB (3 mg/kg IV) induced a statistically significant in power at under Hz for four of four rats (P in power was at and As shown in figure rats that received SCH-23390 (0.2 mg/kg IV) before chloro-APB had only in with no statistically significant at between 0 Hz and 30 Hz. administration of quinpirole (5 mg/kg IV) induced only in electroencephalogram power at under 30 Hz current study was conducted to test the hypothesis that specific dopamine receptor agonists induce emergence from isoflurane anesthesia. The results show that the D1 agonist chloro-APB time to emergence after isoflurane general anesthesia and induces emergence during continuous inhalation of isoflurane. In chloro-APB induces in electroencephalogram power with arousal. The arousal is by the D1 antagonist that the arousal effect is mediated by D1 In the D2 agonist quinpirole failed to induce emergence from isoflurane general a previous was shown that an of dopamine and norepinephrine reuptake induces emergence from isoflurane general was also shown that the arousal-promoting of but both dopaminergic and the specific for the effects of methylphenidate were not The current results show that activation of D1 alone is sufficient to induce emergence from general anesthesia with isoflurane. been reported that chloro-APB and other D1 agonists are that not is that chloro-APB produced a large reduction in time to emergence from isoflurane general anesthesia by a of and similar to the behavioral arousal induced by chloro-APB was not as as the observed previously with is, chloro-APB induced less movements compared to The electroencephalogram were also less methylphenidate and chloro-APB both induced a in methylphenidate chloro-APB did chloro-APB induced a in power at under 30 Hz. these results suggest that chloro-APB induces an arousal compared to This is methylphenidate both dopaminergic and whereas chloro-APB at D1 chloro-APB and quinpirole are widely used in animal studies as specific dopamine receptor and are Although there is that quinpirole also with other than D2 was at inducing emergence from isoflurane anesthesia. we that D2 any other of are to an important role in emergence from general anesthesia. However, we only tested a dose of quinpirole, is but that lower doses have produced an arousal are five of dopamine into two and D1 the D1 and which are and by that of the D1 receptor neurons ascending to the the lateral hypothalamus, and the basal and neurons to the dorsal and the locus of these groups to the whereas through the ventral both of which of specific D1 agonists have been shown to and both movement and movement was previously reported that administration of a D1 receptor time to emergence from anesthesia in with our that chloro-APB induces restoration of righting and electroencephalogram with arousal during continuous isoflurane general anesthesia, is that a D1 arousal plays an important role in emergence from general of dopamine and via activation of that inhibit and D1 D2 are both and and have a effect on arousal. dose-dependent effects on have been at doses of quinpirole mg/kg) and with in movement and movement at doses been that the effects at doses of D2 agonists are mediated through activation of the whereas the in after doses on activation of the D2 the current large doses of (5 mg/kg IV) produced no arousal effect in rats anesthetized with isoflurane. In previous studies using and rats anesthetized with the same dose of quinpirole failed to time to is with our Although D2 agonists have been shown to the sleep–wake the arousal-promoting effects be to induce arousal during general VTA and are the two of dopamine in the that from to the is a of the basal that is for movement loss of neurons to are two pathways that from the the and the The that to the and plays a key role in and which a to the the function of the and in neurons in the VTA and the brain involved in including the of the dorsal the of the locus ceruleus, the of the pedunculopontine and laterodorsal tegmental and the basal and neurons that behavioral in the turn, these areas, as as neurons in the lateral hypothalamus, have inputs to the VTA and lesions of the VTA and in have been reported to induce a of behavioral selective loss of dopamine in mice of these data the that dopaminergic neurons in the VTA or are important for behavioral the specific role of dopamine in arousal remains dopaminergic neurons in the VTA and not mean during the sleep–wake lesions of the ventral the VTA and have been reported to and a group of dopaminergic neurons was in the ventral and been that these be important for regulating of these neurons not been studies are to determine which of dopaminergic neurons is for the arousal effects that to active emergence from general the results of the current study that activation of D1 dopamine is sufficient to induce emergence from isoflurane general anesthesia, whereas activation of D2 does not an arousal under experimental suggest that arousal during general anesthesia is at least in by activation of D1 D1 be a for the of that induce emergence from general define our Bayesian logistic regression we that our experiment used the same six rats at each dose However, the dose were in random order, and the experiments within a rat were by 3 days. a is that the are be the dose level of chloro-APB. are = = = 0.3 and = 3 the dose is normal saline. for = 0 we = to with an be the of righting observed from the six animals at the dose the logistic regression that the of the data n = , or the of = = we a prior for then by the posterior of = is the We the posterior as the mean is the of , and is I the of the observed of the posterior is to the to the posterior under the that the prior of is using the Matlab logistic regression the posterior we compute the posterior densities —P1 for k = by using the following Monte Carlo from Pk = and P1 = Pk —P1 1 to 3 of the Pk —P1 values is a Monte Carlo to the posterior —P1 The lower and upper limits of the 95% Bayesian credibility (confidence) interval are the value and the value in the Monte Carlo respectively. We compute the probability that Pk P1 as P1 = is the of that Pk P1 in the Monte Carlo
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: